Evidence map›Paper›PMID 36769888›Full record

ArticleJournal of clinical medicine2023

Does Post-COVID-19 Erectile Dysfunction Improve over Time?

Alper Gök, Mehmet Altan, Ahmet Emin Doğan, Aşır Eraslan, Fahrettin Şamil Uysal, Ufuk Öztürk, Ardan Muammer Saguner, Muhammet Abdurrahim İmamoğlu

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Alper GökDepartment of Urology, Faculty of Medicine, University of Health Sciences, Ankara 34668, Turkey.
Mehmet AltanDepartment of Urology, Faculty of Medicine, University of Health Sciences, Ankara 34668, Turkey.
Ahmet Emin DoğanDepartment of Urology, Faculty of Medicine, University of Health Sciences, Ankara 34668, Turkey.
Aşır EraslanDepartment of Urology, Faculty of Medicine, University of Health Sciences, Ankara 34668, Turkey.
Fahrettin Şamil UysalDepartment of Urology, Çubuk State Hospital, Ankara 06760, Turkey.
Ufuk ÖztürkDepartment of Urology, Faculty of Medicine, University of Health Sciences, Ankara 34668, Turkey.
Ardan Muammer SagunerDepartment of Cardiology, University Heart Center, University Hospital Zurich, 8091 Zurich, Switzerland.ORCID 0000-0003-1896-0803
Muhammet Abdurrahim İmamoğluDepartment of Urology, Faculty of Medicine, University of Health Sciences, Ankara 34668, Turkey.
Ankara University · TRSivas State Hospital · TRUniversity Hospital of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSome studies have shown that there may be an increase in the frequency of erectile dysfunction after COVID-19. However, no long-term study has investigated whether this is permanent or temporary. In this study, we aimed to examine whether there was an increase in the frequency of erectile dysfunction among individuals with a history of COVID-19, and, if there was, whether their condition improved over time. MATERIALS AND

methodsIn this study, a total of 125 healthy male healthcare workers, 95 with and 30 without a history of COVID-19, were evaluated in terms of erectile function. Four study groups were formed. The first three groups consisted of individuals with a history of COVID-19 confirmed by the polymerase chain reaction (PCR) test at different times, who recovered from the disease (time elapsed since COVID-19 positivity: <6 months for Group 1, 6 to 12 months for Group 2, and >12 months for Group 3). The individuals in Group 4 did not have a history of COVID-19 diagnosis. In order to evaluate the erectile function of the participants, they were asked to complete the five-item International Index of Erectile Function questionnaire (IIEF-5). Then, statistical analyses were performed to evaluate whether there was a difference between the groups in terms of the IIEF-5 scores.

resultsThere was a statistically significant difference between the groups in terms of the IIEF-5 scores (

conclusionThere may be deterioration in erectile function after COVID-19; however, this tends to improve over time, especially from the first year after active infection. Given that vascular, hormonal, and/or psychogenic factors may lead to the development of erectile dysfunction after COVID-19, we consider that in order to easily manage this process, it is important to determine the underlying cause, initiate appropriate treatment, and inform couples that this situation can be temporary.

Indexed as

coronavirusCOVID-19erectile dysfunctionhealthcare professional

Identifiers

PMID36769888
PMCPMC9918199
OpenAlexW4319319277

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.